| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1234682 | Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy | 2012 | 7 Pages |
Resistomycin, a secondary metabolite produced by Streptomyces aurantiacus AAA5. The binding interaction of resistomycin with calf thymus DNA (CT DNA) and bovine serum albumin (BSA) was investigated by spectrophotometry, spectrofluorimetry, circular dichroism (CD) and synchronous fluorescence techniques under physiological conditions in vitro. Absorption spectral studies along with the fluorescence competition with ethidium bromide measurements and circular dichroism clearly suggest that the resistomycin bind with CT DNA relatively strong via groove binding. BSA interaction results revealed that the drug was found to quench the fluorescence intensity of the protein through a static quenching mechanism. The number of binding sites ‘n’ and apparent binding constant ‘K’ calculated according to the Scatchard equation exhibit a good binding property to bovine serum albumin protein. In addition, the results observed from synchronous fluorescence measurements clearly demonstrate the occurrence of conformational changes of BSA upon addition of the test compound.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slideHighlights► Resistomycin is first reported to be produces from S. aurantiacus AAA5. ► First report of DNA and protein binding studies. ► Resistomycin was found to have good binding property. ► Study reveals resistomycin to act as potential drug.
